Archives of General Psychiatry · 1979 · 249 citations · 21 references
Life SciencesNeurosciencePsychiatryNeurochemistryNeuropharmacologyPsychopharmacologyCholinergic PharmacologyGabaergic NeurochemistryGlutamatergic NeurochemistryMonoamine NeurochemistryNeurotransmitter SystemsSerotonergic Pharmacology5-Hydroxytryptamine Receptor PharmacologyGabaergic Neurotransmission In DiseaseMonoamine PharmacologyMuscarinic ReceptorsNeurotransmitter Receptor PharmacologyReceptor Binding ProfilesReceptorsSerotonin Receptor Binding
Frontal cerebral cortex brain samples from schizophrenics and controls have been assayed for binding associated with muscarinic cholinergic, serotonin (5HT), gamma-aminobutyric acid (GABA), and beta-adrenergic receptors as well as for the activity of the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD). Binding levels of tritium-LSD, presumably associated with postsynaptic 5HT receptors, were reduced 40% to 50% in samples from schizophrenics in three independent studies, whereas no other consistent alteration was observed in levels of binding associated with other receptors or in the activity of GAD. This change in receptor binding levels does not seem to be attributable to postmortem changes, to influence of drugs received by the patients, or to demographic features of the patient populations.
21
Drugs, Neurotransmitters, and Schizophrenia
Solomon H. Snyder, Shailesh P. Banerjee, Henry I. Yamamura et al. · Science · 1974 · 835 citations
Medicine, Neuroscience, Pharmacology +16
Serotonergic component of neuroleptic receptors
Josée E. Leysen, C. J. E. Niemegeers, J.P. Tollenaere et al. · Nature · 1978 · 626 citations
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
F. Owen, Timothy J. Crow, Mark Poulter et al. · The Lancet · 1978 · 518 citations
Medicine, Neuroscience, Psychiatry +12